Artificial heart company reassures investors
Thursday, December 19, 2002
BOSTON -- With its clinical trial seemingly ground to a halt, Abiomed Inc. tried to reassure nervous investors about the progress of its self-contained artificial heart.
Subscribe below or log in with your password here.
For more than 115 years, the Southeast Missourian has written the first draft of local history. We have aspired to enrich, entertain, educate and inform. Our core values have remained firm: truth, service, quality, integrity and community. Support our mission.
Join today
Note: Special discounts available to new subscribers only. Print subscriptions may include up to 13 Premium Issues per year, which include special magazines. For each Premium Issue, your account balance will be charged an additional fee in the billing period when the section publishes. This will result in shortening the length of your billing period.